OBENSHAIN ANDREW (President of SGD) sold 3.0% of their position (7.72K shares) of BLUEBIRD BIO, INC. on the open market
Open‑market sale worth $73.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 1/12/2022ACC: 0001562180-22-000441
Officer· President of SGD
Since Jan 2021
-7.72K
Net shares
Net seller
$73.6K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
7.72K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−852.00
Price / share
$9.24
Trade value
$7.88K
% of position
0.3%
1/10/2022
254.42K→253.57K
Common Stock
Direct
Shares
−2.19K
Price / share
$9.40
Trade value
$20.59K
% of position
0.9%
1/10/2022
253.57K→251.38K
Common Stock
Direct
Shares
−4.68K
Price / share
$9.64
Trade value
$45.16K
% of position
1.9%
1/11/2022
251.38K→246.70K
Total
Net shares
−7.72K
Net value
-$73.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/10/2022 | S · Sale | −852.00 | $9.24 | $7.88K | 0.3% | 254.42K | 253.57K |
| Common Stock Direct | 1/10/2022 | S · Sale | −2.19K | $9.40 | $20.59K | 0.9% | 253.57K | 251.38K |
| Common Stock Direct | 1/11/2022 | S · Sale | −4.68K | $9.64 | $45.16K | 1.9% | 251.38K | 246.70K |
| Total | −7.72K | -$73.62K | ||||||
Derivative Transactions0
No derivative transactions reported